|
The Immunohistochemistry Antibody Company
|
|
|
General Cancer Screen 89 Tissue Microarray - LS-SCA89This tissue microarray is available for use in LSBio Immunohistochemistry Studies only. |
| Catalog ID: | LS-SCA89 |
| Product Name: | General Cancer Screen 89 |
| Description: | 12 types of normal and diseased human tissues selected as universal control for >90% routine IHC markers (duplicate cores) |
| Format: | FFPE |
| Category: | Human Multi-Tumor and Normal |
| QA/QC: | H&E reviewed; IHC validated with a positive control antibody |
| Storage: | Short term RT; Long term 4ºC |
| Clinical History: | No |
| Tissue Marker: | Yes |
| Stage/Grade: | Yes |
| Core Diameter: | 1.5 mm |
| Core Thickness: | 4 µm |
| Cases: | 12 |
| Cores: | 24 |
| Slides Per Set: | 1 |
LS-SCA89 Tissue Microarray Map
Slide Number 1
| LABEL |
|
Diagnosis Type Legend
| Benign non-neoplastic | Diseased | Inflammatory | Malignant | Metastatic | Tumor | Unknown |
Element Tissue Legend
Brain, Cortex (Brn); Breast (Bst); Colon (Col); Liver (Liv); Lung (Lng); Placenta (Pla); Prostate (Pst); Skin, Scalp (Skn); Thymus (Tms); Thyroid (Tyd); Tonsil (Tsl); Uterus, Myometrium (Ute);
LS-SCA89 Element Details
| Slide | Position | Species | Gender | Age | Tissue | Diagnosis | Diagnosis Type | ERBB2 (HER2) | Estrogen Receptor (ER) | TNM Tumor Classification | Tumor Stage |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | A1 | Human | M | 9 y | Tonsil (Tsl) | Normal | Benign non-neoplastic | ||||
| 1 | A2 | Human | M | 51 y | Colon (Col) | Normal | Benign non-neoplastic | ||||
| 1 | A3 | Human | F | 19 y | Thyroid (Tyd) | Normal | Benign non-neoplastic | ||||
| 1 | A4 | Human | M | 73 y | Prostate (Pst) | Normal | Benign non-neoplastic | ||||
| 1 | A5 | Human | F | 50 y | Breast (Bst) | Breast carcinoma | Malignant | + | + | T4N3M1 | II-III |
| 1 | A6 | Human | M | 31 y | Thymus (Tms) | Thymoma, Type B | Tumor | ||||
| 1 | B1 | Human | M | 9 y | Tonsil (Tsl) | Normal | Benign non-neoplastic | ||||
| 1 | B2 | Human | M | 51 y | Colon (Col) | Normal | Benign non-neoplastic | ||||
| 1 | B3 | Human | F | 19 y | Thyroid (Tyd) | Normal | Benign non-neoplastic | ||||
| 1 | B4 | Human | M | 73 y | Prostate (Pst) | Normal | Benign non-neoplastic | ||||
| 1 | B5 | Human | F | 50 y | Breast (Bst) | Breast carcinoma | Malignant | T4N3M1 | II-III | ||
| 1 | B6 | Human | M | 31 y | Thymus (Tms) | Thymoma, Type B | Tumor | ||||
| 1 | C1 | Human | M | 16 y | Brain, Cortex (Brn) | Normal | Benign non-neoplastic | ||||
| 1 | C2 | Human | F | 60 y | Lung (Lng) | Normal | Benign non-neoplastic | ||||
| 1 | C3 | Human | M | 59 y | Liver (Liv) | HBV associated cirrhosis | Inflammatory | ||||
| 1 | C4 | Human | F | 38 y | Uterus, Myometrium (Ute) | Normal | Benign non-neoplastic | ||||
| 1 | C5 | Human | U | Placenta (Pla) | Normal | Benign non-neoplastic | |||||
| 1 | C6 | Human | M | 32 y | Skin, Scalp (Skn) | Melanoma | Tumor | ||||
| 1 | D1 | Human | M | 16 y | Brain, Cortex (Brn) | Normal | Benign non-neoplastic | ||||
| 1 | D2 | Human | F | 60 y | Lung (Lng) | Normal | Benign non-neoplastic | ||||
| 1 | D3 | Human | M | 59 y | Liver (Liv) | HBV associated cirrhosis | Inflammatory | ||||
| 1 | D4 | Human | F | 38 y | Uterus, Myometrium (Ute) | Normal | Benign non-neoplastic | ||||
| 1 | D5 | Human | U | Placenta (Pla) | Normal | Benign non-neoplastic | |||||
| 1 | D6 | Human | M | 32 y | Skin, Scalp (Skn) | Melanoma | Tumor |